» Articles » PMID: 25976661

The Natural Phytochemical Dehydroabietic Acid is an Anti-aging Reagent That Mediates the Direct Activation of SIRT1

Overview
Date 2015 May 16
PMID 25976661
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Dehydroabietic acid (DAA) is a naturally occurring diterpene resin acid of confers, such as pinus species (P. densiflora, P. sylvestris) and grand fir (Abies grandis), and it induces various biological actions including antimicrobial, antiulcer, and cardiovascular activities. The cellular targets that mediate these actions are largely unknown yet. In this report, we suggest that DAA is an anti-aging reagent. DAA has lifespan extension effects in Caenorhabditis elegans, prevents lipofuscin accumulation, and prevents collagen secretion in human dermal fibroblasts. We found that these anti-aging effects are primarily mediated by SIRT1 activation. Lifespan extension effects by DAA were ameliorated in sir-2.1 mutants and SIRT1 protein expression was increased, resulting in the deacetylation of SIRT1 target protein PGC-1α. Moreover, DAA binds directly to the SIRT1 protein independent of the SIRT1 substrate NAD(+) levels. Through a molecular docking study, we also propose a binding model for DAA-SIRT1. Taken together, our results demonstrate that the anti-aging effects are the first identified biological property of DAA and that the direct activation of SIRT1 enzymatic activity suggests the potential use of this natural diterpene, or related compounds, in age-related diseases or as a preventive reagent against the aging process.

Citing Articles

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.

Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F Signal Transduct Target Ther. 2024; 9(1):271.

PMID: 39396974 PMC: 11486532. DOI: 10.1038/s41392-024-01969-z.


Decoding the secrets of longevity: unraveling nutraceutical and miRNA-Mediated aging pathways and therapeutic strategies.

Salama R, Eissa N, Doghish A, Abulsoud A, Abdelmaksoud N, Mohammed O Front Aging. 2024; 5:1373741.

PMID: 38605867 PMC: 11007187. DOI: 10.3389/fragi.2024.1373741.


Design, synthesis, and antiproliferative evaluation of novel dehydroabietic acid-1,2,3-triazole-oxazolidinone hybrids.

Wu Y, Huang L, Ma X, Zhou X, Li Q, Li F RSC Med Chem. 2024; 15(2):561-571.

PMID: 38389893 PMC: 10880940. DOI: 10.1039/d3md00550j.


Recent Advances on Biological Activities and Structural Modifications of Dehydroabietic Acid.

Hao M, Xu J, Wen H, du J, Zhang S, Lv M Toxins (Basel). 2022; 14(9).

PMID: 36136570 PMC: 9501862. DOI: 10.3390/toxins14090632.


Synthesis and biological evaluation of 2-aryl-benzimidazole derivatives of dehydroabietic acid as novel tubulin polymerization inhibitors.

Miao T, Tao X, Li D, Chen H, Jin X, Geng Y RSC Adv. 2022; 8(31):17511-17526.

PMID: 35539265 PMC: 9080489. DOI: 10.1039/c8ra02078g.